
Education
CME Case Study—Part 2 Earn free CME credit by participating in the 3-part TU CME Case Study, which follows a patient over the course of 9 months of office visits. A patient history, lab results, and office notes are followed by multiple-choice questions to elicit the diagnosis and treatment plan. Part 1 of the case study is still available for credit, and Part 2 is now posted. Once Part 3 is posted, a reminder e-mail will be sent to participants to continue the CME activity.
CME Case Study—Part 1 Earn free CME credit by participating in the 3-part TU CME Case Study, which follows a patient over the course of 9 months of office visits. A patient history, lab results, and office notes are followed by multiple-choice questions to elicit the diagnosis and treatment plan. Participants may receive CME credit upon completion of each installment of the case study. As parts 2 and 3 are posted, reminder e-mails will be sent to participants to continue the CME activity.
Downloadable TU Toolkit Four clinical tools support hypogonadism diagnosis, management, and patient care, including tips on raising patient awareness about hypogonadism.
Testosterone Update Town Hall Forum Proceedings TestosteroneUpdate Distinguished Faculty convened to discuss cutting-edge information concerning the diagnosis and treatment of hypogonadism, with the goal of increasing awareness about this underrecognized and undertreated condition.
Earn up to 1.5 AMA PRA Category 1 Credits™.
American Urological Association Conference Courier Highlights Report on Hypogonadism The treatment of hypogonadism was one of the state-of-the-art topics at the Annual Meeting of the American Urological Association held April 25 to April 30, 2009, in Chicago, Illinois.
Endocrine Society Conference Courier Highlights Report on Hypogonadism The treatment of hypogonadism was one of the state-of-the-art topics at the annual meeting of the Endocrine Society held in Washington, DC, June 10 to 13, 2009.
Frequently Asked Questions This downloadable reference guide answers commonly asked questions about the diagnosis, management, and treatment of hypogonadism. Topics include comorbidities, efficacy and safety of testosterone therapy, and tips for optimizing long-term persistence with testosterone therapy and treatment success.
Highlights From Disease State Theater Experts from the fields of endocrinology, primary care, and urology presented at the 2008 American Urological Association and Endocrine Society annual meetings on treatment of hypogonadism in men. The proceedings from these meetings review the current data on hypogonadism and offer recommendations that can be incorporated into your clinical practice.
Multidisciplinary Insights Into the Assessment, Diagnosis, and Management of Hypogonadism Experts from the fields of endocrinology, primary care, and urology participated in a roundtable discussion focusing on the diagnosis and treatment of hypogonadism in men.
Proceedings From the TU 1st Annual Conference on Improving Clinical Outcomes in Hypogonadism Physicians at the forefront of treatment and research presented and discussed treatment considerations in the management of hypogonadism.
Emerging Evidence and Future Directions in Treating Hypogonadism This informative monograph was co-authored by Adrian S. Dobs, MD, MHS, and Frances J. Hayes, MD.
Optimizing Patient Safety in the Management of Hypogonadism This satellite symposium was presented at the 16th Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists.





